Last €26.84 EUR
Change Today +0.042 / 0.16%
Volume 0.0
LDU On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:03 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

landauer inc (LDU) Snapshot

Open
€26.84
Previous Close
€26.80
Day High
€26.84
Day Low
€26.84
52 Week High
12/2/13 - €38.88
52 Week Low
08/21/14 - €26.80
Market Cap
256.4M
Average Volume 10 Days
52.0
EPS TTM
--
Shares Outstanding
9.6M
EX-Date
06/10/14
P/E TM
--
Dividend
€2.16
Dividend Yield
6.05%
Current Stock Chart for LANDAUER INC (LDU)

Related News

No related news articles were found.

landauer inc (LDU) Related Businessweek News

No Related Businessweek News Found

landauer inc (LDU) Details

Landauer, Inc., together with its subsidiaries, provides technical and analytical services, outsourced medical physics services, and radiology related medical products Worldwide. The company operates in three segments: Radiation Measurement, Medical Physics, and Medical Products. The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure; manufactures various radiation detection monitors; and distributes and collects monitors to and from customers, as well as analyzes and reports exposure findings. It also leases or sells dosimetry detectors and reading equipment. This segment provides its services primarily to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities, and other industries in which radiation poses a potential threat to employees. The Medical Physics segment offers therapeutic and imaging physics services comprising clinical physics support, equipment commissioning, accreditation support, and imaging equipment testing to hospitals, radiation therapy centers, and imaging centers. The Medical Products segment provides medical consumable accessories that are used in radiology, radiation therapy, and image guided surgery procedures. The company was founded in 1954 and is based in Glenwood, Illinois.

650 Employees
Last Reported Date: 06/2/14
Founded in 1954

landauer inc (LDU) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $588.1K
Vice President of Global Marketing and Presid...
Total Annual Compensation: $245.1K
President of Radiation Measurement
Total Annual Compensation: $298.1K
Senior Vice President of Technology and Inter...
Total Annual Compensation: $270.1K
Compensation as of Fiscal Year 2013.

landauer inc (LDU) Key Developments

Landauer Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2014; Provides Earnings Guidance for the Fiscal 2014; Reports Impairment Charges

Landauer Inc. announced consolidated earnings results for the third quarter and nine months ended June 30, 2014. For the quarter, the company reported net revenue was $34.77 million against $36.58 million a year ago. Operating loss was $60.76 million against $16.78 million a year ago. Loss before taxes was $61.35 million against $17.35 million a year ago. Net loss attributable to the company was $36.63 million or $3.86 basic and diluted per share against $13.75 million or $3.86 basic and diluted per share a year ago. The decrease in net income was due to the impairment charge of $62.2 million and to $1.6 million of reorganization expenses, partially offset by a larger tax benefit. Loss before interest, taxes, depreciation and amortization was $57 million against $12.57 million a year ago. Adjusted EBITDA was $7.36 million against $11.06 million a year ago. The decrease in EBITDA was due primarily to reduced gross margin of $1.8 million, an increase in bad debt expense of $0.7 million, outside services of $0.5 million along with a decrease in equity income of joint ventures of $0.2 million due to the timing of military orders. Adjusted net loss was $0.696 million or $0.07 diluted loss per share against income of $4.77 million or $0.51 diluted per share a year ago. Operating income, adjusted for the impairment charge and reorganization costs (primarily severance costs) recorded during the third fiscal quarter of 2014, was $3.0 million. Operating income, adjusted for the $22.7 million impairment charge for the third fiscal quarter of 2013, was $5.9 million. For the nine months, the company reported net revenue was $112.02 million against $110.34 million a year ago. Operating loss was $48.37 million against $2.89 million a year ago. The higher loss was due primarily to an increase in goodwill and intangible assets impairments as well as reorganization costs. Loss before taxes was $49.69 million against $3.18 million a year ago. Net loss attributable to the company was $28.58 million or $3.02 basic and diluted per share against $3.72 million or $0.40 basic and diluted per share a year ago, primarily due to the impairment charge of $62.2 million. Loss before interest, taxes, depreciation and amortization was $36.18 million against profit of $10.24 million a year ago. Adjusted EBITDA was $28.87 million against $35.44 million a year ago. The decrease in EBITDA was due primarily to reduced gross margin of $1.2 million, an increase in research and development expenses of $2.1 million, bad debt expense of $0.8 million, outside services of $0.7 million along with a decrease in equity income of joint ventures of $1.2 million due to the timing of military orders. Adjusted net income was $8.24 million or $0.87 diluted per share against income of $22.64 million or $2.41 diluted per share a year ago. Net cash provided by operating activities was $26.68 million against $19.58 million a year ago. Capital expenditure was $3.06 million against $8.13 million a year ago. For the third quarter, the company reported goodwill and other intangible impairment charges was $62.19 million against $22.7 million a year ago. For the fiscal 2014, the company expected revenue reaffirmed at a range of $150 million to $160 million; Adjusted EBITDA reaffirmed at a range of $44 million to $46 million; Adjusted net income reaffirmed at a range of $16 million to $18 million without the effect of impairment charges taken in the quarter. The effective tax rate for the full fiscal year is anticipated to be within a range of 42% to 45%. Excluding the impact of the goodwill and intangible assets impairment, the effective tax rate would range from 25% to 30%.

Landauer Inc. to Report Q3, 2014 Results on Aug 04, 2014

Landauer Inc. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Aug 04, 2014

Landauer Inc., Q3 2014 Earnings Call, Aug 05, 2014

Landauer Inc., Q3 2014 Earnings Call, Aug 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LDU:GR €26.84 EUR +0.042

LDU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LDU.
View Industry Companies
 

Industry Analysis

LDU

Industry Average

Valuation LDU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.2x
Price/Book 13.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANDAUER INC, please visit www.landauerinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.